Study establishes proof of concept for TLX592 in prostate cancer
Preliminary results from the CUPID study were based on data from 11 evaluable patients with advanced prostate cancer.
Preliminary results from the CUPID study were based on data from 11 evaluable patients with advanced prostate cancer.
Dietitian-led interventions can help patients with CKD optimize their nutritional status.
Serum chloride is a novel biomarker of atrial fibrillation risk among patients with CKD.
In the EMBARK trial in patients with nonmetastatic hormone-sensitive prostate cancer, patients with good PSA responses at 37 weeks had their treatment suspended until their…
Adding cabazitaxel to abiraterone acetate and prednisone significantly reduced the risk of disease progression or death in patients with mCRPC previously treated with ADT plus…
This link will take you to a page that’s not on LinkedIn
In this final special edition of episodes recorded live at EAU24, our experts (Panel Chair Prof. Jean-Nicolas and panel member Dr. Manuela Tutolo) discuss the…
Christos Kyriakopoulos describes the outcome of this study, where cabazitaxel with abiraterone as combined with abiraterone alone in docetaxel refractory CRPC.
Antinephrin autoantibody titers might be used to guide therapy, according to investigators.
This monotherapy was safe for all doses and dosing schedules observed in the study and daily doses showed initial antitumor activity.
Neoadjuvant therapy with sacituzumab govitecan demonstrated hypothesis generating complete responses following surgery with tolerable toxicity after a protocol amendment requiring a dose reduction and G-CSF…